A convergence of factors has JPMorgan Chase & Company NYSE: JPM stock poised to rally in 2026. The stock surged in 2025 and could advance as much as 20% by year's end.
JPMorgan Chase & Co. (JPM) Q4 2025 Earnings Call Transcript
JPMorgan Chase & Co (NYSE:JPM, XETRA:CMC) saw its shares fall 3.5% on Tuesday after the bank reported fourth-quarter 2025 results, with investment banking fees falling short of analyst expectations. Fees totaled $2.35 billion, down 5% from a year earlier and 11% from the prior quarter, compared with the $2.5 to $2.6 billion that analysts had forecast, reflecting weaker-than-expected advisory and deal activity.
A new Inflation Rate hits the tape this morning, coming in flat month over month to +2.7% — still -30 basis points (bps) from the recent high +3.0% back in September. It continues an abrupt turnaround in Consumer Price Index (CPI) year over year, which had risen +70 bps from April to September of last year.
JPMorgan's investment-banking fees unexpectedly fell in the fourth quarter, while the bank delivered results that otherwise mostly beat consensus. Dani Burger reports on Bloomberg Television.
JPMorgan's Q4 earnings beat estimates as trading and NII surge, but weak investment banking weighs on results.
Although the revenue and EPS for JPMorgan Chase & Co. (JPM) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Markets are moving in a healthy direction, according to Kevin Green. He points to a broadening SPX and cooled volatility backing his thesis.
In two decades, Dimon took a middle-of-the-pack American lender and created a juggernaut of finance that the world hadn't seen before. Dimon has for years maintained that his retirement was perpetually 5 years away.
JPMorgan's earnings are not just a bank report, but the opening signal of earnings season. As the largest U.S. bank, JPMorgan offers a real-time snapshot of the economy, and its results reveal how growth and monetary policy interact. This article looks beyond the EPS level. The key question is what JPMorgan's earnings say about the economy, setting the tone for the rest of the month.
At the JPMorgan Healthcare Conference, drugmakers are expected to roll out key business and drug pipeline updates and splashy M&A deals.
A flood of banking earnings with hit investors next week to kick off 2026's first earnings season. Stephen Biggar expects the biggest banks like JPMorgan Chase (JPM), Wells Fargo (WFC), and Goldman Sachs (GS) to experience "more of the same" uptrend thanks to fortress-like balance sheets and a favorable economic environment.